Clinical Guidelines

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program

Share

  • 1

    ITP is characterized by megakaryocyte destruction and low platelet counts.

  • 2

    Symptoms include bleeding, petichiae, and gingival bleeding.

  • 3

    Treatment varies by patient, with corticosteroids being common.

  • 4

    ITP can be acute, persistent, or chronic.

  • 5

    Advocacy and understanding patient experiences are key in care improvement.

Original Source(s)

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program

  • by Michael Tarantino, MD, David Dubinski, MBA, Corey Falcon, MD, Leslie Ferber, MPH, Patrick Foy, MD, Stephanie Johnston, MSN, APRN, FNP-C, AOCNP, Susan Kirk, PA-C, Michele P. Lambert, MD, MSTR, Farishta Manzoor, PharmD, Vlad Radulescu, MD, Iberia Romina Sosa, MD, PhD, Porcher Scott

  • March 9, 2026

  • 17 min

Related Content

Optimizing the Care of Patients With Higher-Risk Myelofibrosis

Navigating Complex Cases With Empathetic Communication

Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Monocytosis

The second case in our series on myeloid neoplasms